Article
CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapy
2025-01-09
Abstract excerpt
Immuno-oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification. This review provides an overview of recent advancements in the application of CRISPR/Cas9-edit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f65c4ec1-bca4-5eba-b9d2-1b833dd9cf1f
- DOI
- 10.22541/au.173639048.85724396/v1
